Craig-Hallum analyst Alex Fuhrman initiated coverage of LifeVantage (LFVN) with a Buy rating and $35 price target
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFVN:
- LifeVantage announces results of third-party cell study of health weight stack
- LifeVantage launches 2025 vision with ‘Drive ERA’
- LifeVantage price target raised to $30 from $26 at Lake Street
- Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
- Morning Movers: AngioDynamics jumps following results and guidance raise